Logo

PerkinElmer Board Declares Dividend

Jan 26, 2010

NEW YORK (Genomeweb News) – The board of directors of PerkinElmer has declared a quarterly dividend of $.07 per share.

The dividend is payable on May 7 to shareholders of record as of the close of business on April 16.

PerkinElmer is scheduled to release its fourth-quarter and full-year 2009 results on Feb. 4. Analysts expect, on average, the firm to report Q4 revenues of $479.5 million and earnings per share of $.41.

Filed under

dividend
PerkinElmer
Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.